Latest Earnings Analysis

• BioNTech (BNTX) Q4 2023: R&D Spend to Rise 44% as Oncology Pipeline Targets $10B+ Opportunity
  March 20, 2024 · BNTX
• Caleres (CAL) Q4 2023: Brand Portfolio Margin Surges 570 bps, Anchoring Profit Shift
  March 19, 2024 · CAL
• Bridger Aerospace (BAER) Q4 2023: Gross Margin Expands 11 Points as Fleet and Tech Scale Despite Cost Surge
  March 19, 2024 · BAER
• ABEO Q4 2023: $52.6M Cash Runway Secures PZ-Cell Launch Readiness Ahead of May FDA Decision
  March 18, 2024 · ABEO
• Alti (ALTI) Q4 2023: $450M Strategic Capital Infusion Anchors M&A Growth Pipeline
  March 15, 2024 · ALTI
• BKE Q4 2023: Deposit Base Expands 52% as American River Acquisition Drives Scale
  March 15, 2024 · BKE
• Aviana (AVAH) Q4 2023: 19 State Rate Wins Drive Margin Resilience, Preferred Payer Model Scales
  March 14, 2024 · AVAH
• BGSF (BGSF) Q4 2023: Adjusted EBITDA Margin Rises to 8% as Strategic Shift Powers Operating Leverage
  March 14, 2024 · BGSF
• Allogene (ALLO) Q4 2023: $3B Alpha-3 LBCL Opportunity Anchors Strategic Pivot to Frontline and Autoimmune Expansion
  March 14, 2024 · ALLO
• KE Holdings (BEKE) Q4 2023: Home Renovation Revenue Jumps 74% as Platform Diversifies Beyond Brokerage
  March 14, 2024 · BEKE
• Alta Equipment Group (ALTG) Q4 2023: Equipment Sales Jump $205M, Locking in Multi-Year Product Support Tailwind
  March 14, 2024 · ALTG
• Blend (BLND) Q4 2023: RPO Jumps $35M as Consumer Banking Pipeline Hits 70 Opportunities
  March 14, 2024 · BLND
• BK Technologies (BKTI) Q4 2023: BKR 9000 Drives 37% Unit Growth as Margins Rebound to 35%
  March 14, 2024 · BKTI
• BW (BW) Q4 2023: $9B Pipeline Fuels Shift to High-Margin Decarbonization and Services
  March 14, 2024 · BW
• Acacia Research (ACTG) Q4 2023: Book Value Per Share Jumps 14% on IP Monetization and Benchmark Energy Scale-Up
  March 14, 2024 · ACTG
• Afya (AFYA) Q4 2023: B2B Digital Revenue Jumps 64%, Fueling Margin Expansion Narrative
  March 14, 2024 · AFYA
• AGEN Q4 2023: $250M Partner Milestone Sets Stage for Accelerated Oncology Expansion
  March 14, 2024 · AGEN
• Adobe (ADBE) Q1 2024: RPO Jumps 16% as GenAI Monetization Accelerates, Setting Up Second-Half ARR Ramp
  March 14, 2024 · ADBE
• Build-A-Bear Workshop (BBW) Q4 2023: 50-Store Expansion to Accelerate Asset-Light Model and Brand Reach
  March 14, 2024 · BBW
• Brilliant Earth (BRLT) Q4 2023: Fine Jewelry Bookings Jump 28% as Mix Shift Accelerates Brand Expansion
  March 14, 2024 · BRLT
• Beaufort Capital (BUR) Q4 2023: Portfolio Up 17% as Realizations Broaden Beyond YPF
  March 14, 2024 · BUR
• Autolus Therapeutics (AUTL) Q4 2023: BioNTech Alliance Adds $250M, Extending Cash Runway for OB-Cell Launch
  March 14, 2024 · AUTL
• American Vanguard (AVD) Q4 2023: Pathfinder Targets $15M EBITDA Uplift by 2026 Amid Rebound
  March 14, 2024 · AVD
• ProFrac (ACDC) Q4 2023: Free Cash Flow Jumps 173% as Utilization Focus Drives Turnaround
  March 13, 2024 · ACDC
• ADC Therapeutics (ADCT) Q4 2023: Zynlonta Net Revenue Climbs 17% as Pipeline Refocuses on Hematology and Next-Gen ADCs
  March 13, 2024 · ADCT
• Anika (ANIK) Q4 2023: $10M Cost Cuts and 75% EBITDA Jump Signal Accelerated Profitability Pivot
  March 13, 2024 · ANIK
• Arcos Dorados (ARCO) Q4 2023: Digital Sales Climb 39%, Accelerating Loyalty and Freestanding Expansion
  March 13, 2024 · ARCO
• BRT Apartments (BRT) Q4 2023: $16.7M Buyback Signals Defensive Capital Allocation Amid Sun Belt Supply Pressure
  March 13, 2024 · BRT
• BWMN Q4 2023: Backlog Climbs $63M as Diversification Drives Double-Digit Growth
  March 12, 2024 · BWMN
• BioVentus (BVS) Q4 2023: Pain Treatments Surge 23% as Turnaround Accelerates
  March 12, 2024 · BVS
• Be Light Bio (BLTE) Q4 2024: Phase 3 Dragon Trial DSMB Endorsement Signals Accelerated Path for Teneraband
  March 12, 2024 · BLTE
• BioT (BTMD) Q4 2023: BioTRx Launch and 403bp Margin Expansion Signal Competitive Reset
  March 12, 2024 · BTMD
• BTAI Q4 2023: Cash Runway Shrinks to Mid-2024 as Tranquility and Serenity Prioritized
  March 12, 2024 · BTAI
• AWRE Q4 2023: ARR Climbs 23% as Subscription Model Fuels Recurring Revenue Base
  March 12, 2024 · AWRE
• Broadcom (AVGO) Q1 2020: Software Revenue Rises 19% as Hardware Uncertainty Forces Guidance Withdrawal
  March 12, 2024 · AVGO
• Casey's (CASY) Q3 2024: Prepared Food Margin Climbs 230bps, Reinforcing Differentiation Strategy
  March 12, 2024 · CASY
• Allbirds (BIRD) Q4 2023: Inventory Slashed 51% as Distributor Model Reshapes Profit Path
  March 12, 2024 · BIRD
• BZ Q4 2023: Paid Enterprise Customers Surge 44%, Unlocking Margin Expansion and User Diversification
  March 12, 2024 · BZ
• ADM (ADM) Q4 2024: $500M Cost-Out Plan Targets Margin Recovery Amidst Biofuel and Demand Uncertainty
  March 12, 2024 · ADM
• Alto Ingredients (ALTO) Q4 2023: CCS Project Takes Priority as $27M EBITDA Upswing Reshapes Capital Allocation
  March 11, 2024 · ALTO
• Mission Produce (AVO) Q1 2024: Blueberry Segment Drives 69% Gross Profit Surge Amid Margin Expansion
  March 11, 2024 · AVO
• Ballard Power (BLDP) Q4 2023: Record $64.7M Orders Signal Demand Shift as Gross Margin Nears Breakeven
  March 11, 2024 · BLDP
• Asana (ASAN) Q4 2024: 20,000 AI Tier Adoptions Signal Upmarket Expansion and Profitability Pivot
  March 11, 2024 · ASAN
• CANG Q4 2023: Platform Integration Drives 75,000+ SKU Export Launch Amid Revenue Reset
  March 11, 2024 · CANG
• AQN Q4 2023: Regulated Operating Profit Climbs 10% as Pure-Play Utility Pivot Accelerates
  March 08, 2024 · AQN
• AirSculpt Technologies (ASLE) Q4 2023: $329M Inventory Sets Up Multi-Channel Monetization, Guidance Pulled Amid Forecasting Complexity
  March 07, 2024 · ASLE
• Broadcom (AVGO) Q1 2024: AI Revenue to Surpass $10B, Now 35% of Semiconductor Sales
  March 07, 2024 · AVGO
• ABM (ABM) Q1 2024: Aviation Surges 18% as Microgrid Backlog Hits $590M, Margin Recovery in Sight
  March 07, 2024 · ABM
• Arcturus Therapeutics (ARCT) Q4 2023: $396M Milestone Payments Extend Runway, Vaccine Platform Validated
  March 07, 2024 · ARCT
• AMTX Q4 2023: India Biodiesel Hits $150M Allocation, Sets Stage for IPO and SAF Expansion
  March 07, 2024 · AMTX